reference/27007560

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27007560

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	67141
issn	1949-2553
issueIdentifier	41
pageRange	67129-67141
publicationName	Oncotarget
startingPage	67129
bibliographicCitation	Lu Q, Wang L, Zhang Y, Yu X, Wang C, Wang H, Yang Y, Chong X, Xia T, Meng Y, Wang Y, Lu C, Zhou L, Li B. An anti-ErbB2 fully human antibody circumvents trastuzumab resistance. Oncotarget. 2016 Oct 11;7(41):67129–41. PMID: 27564098; PMCID: PMC5341862.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d37345f65a65ec27fc3b99f31dec29cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e887ec6da75a0c260970779e9400b90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0f070d5dcd45e4711733480cf9e9a10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab5dee62b958ae0c87c59e60d1264f6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0659bdcd15e12ff9db639d0e54a75ace http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f50dc1d3c70ed45f75a3953f0d0e82e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a422ee4e45e9d76caf9a549c836bb047 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17ca41660a14d373b62a65fd59fb9f67 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b33d3ecd2ed2ee1abc48f604dec3c497 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a8c980c66410142d6564643d07bac37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_472f002e14931dcc4ac459e40979ce34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44f305fb7b2ab50d9f6c26ccf7b50246 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd0a394fea104dcdb9a652fa1affbcfa
date	2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/27564098 https://pubmed.ncbi.nlm.nih.gov/PMC5341862 https://doi.org/10.18632/oncotarget.11562
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803 https://portal.issn.org/resource/ISSN/1949-2553
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	An anti-ErbB2 fully human antibody circumvents trastuzumab resistance
discusses	http://id.nlm.nih.gov/mesh/M0495206 http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0291428 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000911Q000494 http://id.nlm.nih.gov/mesh/D018719Q000037 http://id.nlm.nih.gov/mesh/D001943 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D019008Q000187
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068878 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Total number of triples: 55.